+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
Pulmonary Sarcoidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Sarcoidosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Recurrent Herpes Labialis - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Herpes Labialis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Stargardt Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Stargardt Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Sternal Wound Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Sternal Wound Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Subarachnoid Hemorrhage- Pipeline Insight, 2025 - Product Thumbnail Image

Subarachnoid Hemorrhage- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sudden Sensorineural Hearing Loss (SSNHL) - Pipeline Insight, 2025 - Product Thumbnail Image

Sudden Sensorineural Hearing Loss (SSNHL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Syphilis - Pipeline Insight, 2025 - Product Thumbnail Image

Syphilis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Systemic Scleroderma - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Scleroderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Systemic Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Systemic Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Thalassemia- Pipeline Insight, 2025 - Product Thumbnail Image

Thalassemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Thrombotic Microangiopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Thrombotic Microangiopathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Meningitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Meniere's Disease (MD) - Pipeline Insight, 2025 - Product Thumbnail Image

Meniere's Disease (MD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Memory Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Memory Disorders - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Meconium Aspiration Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Meconium Aspiration Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mastocytosis - Pipeline Insight, 2025 - Product Thumbnail Image

Mastocytosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Malignant Pleural Effusion - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Pleural Effusion - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Major Depressive Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more